Literature DB >> 18775539

Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents.

Lian-Yu Lin1, Hsu-Ko Kuo, Juey-Jen Hwang, Ling-Ping Lai, Fu-Tien Chiang, Chuen-Den Tseng, Jiunn-Lee Lin.   

Abstract

OBJECTIVE: Bilirubin is a potent antioxidant and a cyroprotectant. Low serum bilirubin is associated with atherosclerosis. Little is known about its role in metabolic syndrome (MS) among children and adolescents.
METHODS: We examined 4723 children and adolescents aged 12-17 years with reliable measures of various serum hepatic profiles and metabolic risks from Health and Nutrition Examination Survey 1999-2004.
RESULTS: The results showed that the prevalence of the MS was from 6.6+/-1.2% in the lowest quartile to 2.1+/-1.9% in the highest quartile of the concentration of total bilirubin. The graded association remained significant after the adjustment of other co-variates. The odds ratios for the MS were around 0.29 (0.08-0.99) and 0.23 (0.08-0.65) for the upper two quartiles when using the lowest quartile as reference for the concentration of total bilirubin. The quartiles of the serum total bilirubin levels were inversely correlated with the homeostasis model assessment (HOMA-IR) and insulin while not associated with the serum C-reactive protein (CRP) levels.
CONCLUSIONS: The serum total bilirubin levels are inversely correlated with the prevalence of the MS. The mechanism of the association between MS and total bilirubin may be related to the insulin resistance status.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775539     DOI: 10.1016/j.atherosclerosis.2008.07.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  42 in total

Review 1.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

Review 2.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

3.  Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.

Authors:  Satoshi Yoshino; Shuichi Hamasaki; Sanemasa Ishida; Tetsuro Kataoka; Akiko Yoshikawa; Naoya Oketani; Keishi Saihara; Hitoshi Ichiki; So Kuwahata; Shoji Fujita; Takuro Takumi; Issei Yoshimoto; Mitsuhiro Nakazaki; Chuwa Tei
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

4.  Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population.

Authors:  Jaeseong Jo; Ji Eun Yun; Heeyeon Lee; Heejin Kimm; Sun Ha Jee
Journal:  Endocrine       Date:  2010-11-30       Impact factor: 3.633

5.  Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Kosuke Masutani; Masaharu Nagata; Akihiro Tsuchimoto; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin Exp Nephrol       Date:  2015-02-21       Impact factor: 2.801

6.  Bilirubin levels in patients with systemic lupus erythematosus: increased or decreased?

Authors:  Zaixing Yang; Yan Liang; Chang Li; Weiqiang Xi; Renqian Zhong
Journal:  Rheumatol Int       Date:  2011-06-21       Impact factor: 2.631

7.  Relation of total bilirubin and QT interval prolongation (from the Third National Health and Nutrition Examination Survey).

Authors:  Chaudry N Majeed; Muhammad I Ahmad; Irfan Ahsan; Muhammad A Anees; Sanjay K Maheshwari; Elsayed Z Soliman
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-09       Impact factor: 1.468

Review 8.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

9.  The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.

Authors:  Libor Vítek
Journal:  Front Pharmacol       Date:  2012-04-03       Impact factor: 5.810

10.  Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.

Authors:  Byoung Kuk Jang
Journal:  Clin Mol Hepatol       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.